What is the address of Phase 3?

The registered office of Phase 3 is located at Rue des Mousquetaires Gris 35, 5660 Couvin.

Is Phase 3 still active?

Yes. According to the CBE (29 October 2026) Phase 3 is active, legal situation “Normale toestand”, started on 6 August 1979.

Is Phase 3 registered on Peppol?

Yes, Phase 3 is registered on the Peppol network with ID 0208:0419617446.

What is the enterprise number of Phase 3?

The enterprise number of Phase 3 is BE0419617446.

When was Phase 3 founded?

Phase 3 was founded on 6 August 1979.

Who are the directors of Phase 3?

According to the 2025 annual accounts, the directors of Phase 3 are: ExecAdvice, JEAN CLAUDE BIARD, AQLC Management SRL, Noélise Consulting SRL.

Is Phase 3 a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 August 1979; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Phase 3 make in 2025?

Phase 3 posted a profit after taxes of € 132,142 in financial year 2025.

What is the revenue of Phase 3?

As a small company, Phase 3 is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 312,699.

How much does an employee at Phase 3 earn?

The average wage cost per full-time employee at Phase 3 was € 53,800 in 2025: staff costs of € 123,758 for 2.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Phase 3 have?

According to the 2025 annual accounts, Phase 3 has 2.3 full-time equivalents (FTE).

Phase 3 (Private Limited) - Couvin - BE0419617446

Q: What does Phase 3 do?

Phase 3 is registered with the CBE as active in: Vervaardiging van andere anorganische chemische basisproducten. Private Limited, started on 6 August 1979, 1 establishment.

Dossier Phase 3, printed on 29 October 2026 from databakkes.be/en/0419617446/phase-3. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Phase 3 from Couvin, company number BE0419617446, closed financial year 2025 with a result of € 132,142 after tax. For that financial year Phase 3 recorded a gross margin of € 312,699 and equity of € 180,194. Compared with financial year 2024, the result moved from € 97,466 to € 132,142. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What it is worth Growing

€ 180,194

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 132,142

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 182,290

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,000 paid out

98 % of the profit went to the shareholders, mostly to B-CHEMICALS INTERNATIONAL HOLDING (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.3

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 123,758

▲ 22% vs 2024

€ 53,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,104

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 25,013

▼ 19% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 12,834

▲ 224% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 5,657

▼ 48% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 271,253 Gross margin 2022: € 271,253 First fiscal year in the series	€ 210,080 Gross margin 2023: € 210,080 ▼ 23% vs 2022 (€ 271,253) Unfavourable step	€ 244,188 Gross margin 2024: € 244,188 ▲ 16% vs 2023 (€ 210,080) Favourable step	€ 312,699 Gross margin 2025: € 312,699 ▲ 28% vs 2024 (€ 244,188) Favourable step	▲ 28%
Profit after taxes	€ 89,465 Profit after taxes 2022: € 89,465 First fiscal year in the series	€ 92,539 Profit after taxes 2023: € 92,539 ▲ 3% vs 2022 (€ 89,465) Favourable step	€ 97,466 Profit after taxes 2024: € 97,466 ▲ 5% vs 2023 (€ 92,539) Favourable step	€ 132,142 Profit after taxes 2025: € 132,142 ▲ 36% vs 2024 (€ 97,466) Favourable step	▲ 36%
Equity	€ 130,546 Equity 2022: € 130,546 First fiscal year in the series	€ 130,585 Equity 2023: € 130,585 Unchanged (€ 130,546) Favourable step	€ 178,051 Equity 2024: € 178,051 ▲ 36% vs 2023 (€ 130,585) Favourable step	€ 180,194 Equity 2025: € 180,194 ▲ 1% vs 2024 (€ 178,051) Favourable step	▲ 1%
Total debts	€ 239,291 Total debts 2022: € 239,291 First fiscal year in the series	€ 136,216 Total debts 2023: € 136,216 ▼ 43% vs 2022 (€ 239,291) Favourable step	€ 95,732 Total debts 2024: € 95,732 ▼ 30% vs 2023 (€ 136,216) Favourable step	€ 173,522 Total debts 2025: € 173,522 ▲ 81% vs 2024 (€ 95,732) Unfavourable step	▲ 81%
Cash	€ 84,090 Cash 2022: € 84,090 First fiscal year in the series	€ 126,018 Cash 2023: € 126,018 ▲ 50% vs 2022 (€ 84,090) Favourable step	€ 173,248 Cash 2024: € 173,248 ▲ 37% vs 2023 (€ 126,018) Favourable step	€ 182,290 Cash 2025: € 182,290 ▲ 5% vs 2024 (€ 173,248) Favourable step	▲ 5%
Retained profit	€ 105,546 Retained profit 2022: € 105,546 First fiscal year in the series	€ 105,585 Retained profit 2023: € 105,585 Unchanged (€ 105,546) Favourable step	€ 153,051 Retained profit 2024: € 153,051 ▲ 45% vs 2023 (€ 105,585) Favourable step	€ 155,194 Retained profit 2025: € 155,194 ▲ 1% vs 2024 (€ 153,051) Favourable step	▲ 1%
Dividend	€ 89,000 Dividend 2022: € 89,000 First fiscal year in the series	€ 92,500 Dividend 2023: € 92,500 ▲ 4% vs 2022 (€ 89,000) Unchanged	€ 50,000 Dividend 2024: € 50,000 ▼ 46% vs 2023 (€ 92,500) Unchanged	€ 130,000 Dividend 2025: € 130,000 ▲ 160% vs 2024 (€ 50,000) Unchanged	▲ 160%
Bank debt	€ 29,198 Bank debt 2022: € 29,198 First fiscal year in the series	€ 23,500 Bank debt 2023: € 23,500 ▼ 20% vs 2022 (€ 29,198) Favourable step	€ 30,764 Bank debt 2024: € 30,764 ▲ 31% vs 2023 (€ 23,500) Unfavourable step	€ 25,013 Bank debt 2025: € 25,013 ▼ 19% vs 2024 (€ 30,764) Favourable step	▼ 19%
Balance sheet total	€ 369,837 Balance sheet total 2022: € 369,837 First fiscal year in the series	€ 266,801 Balance sheet total 2023: € 266,801 ▼ 28% vs 2022 (€ 369,837) Unchanged	€ 273,783 Balance sheet total 2024: € 273,783 ▲ 3% vs 2023 (€ 266,801) Unchanged	€ 353,715 Balance sheet total 2025: € 353,715 ▲ 29% vs 2024 (€ 273,783) Unchanged	▲ 29%
Employees (FTE)	2.3 Employees (FTE) 2022: 2.3 First fiscal year in the series	1.8 Employees (FTE) 2023: 1.8 ▼ 0.5 vs 2022 (2.3) Unchanged	2.2 Employees (FTE) 2024: 2.2 ▲ 0.4 vs 2023 (1.8) Unchanged	2.3 Employees (FTE) 2025: 2.3 ▲ 0.1 vs 2024 (2.2) Unchanged	▲ 0.1

Key figures of Phase 3, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Phase 3?

What happened at Phase 3 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 26, 2026 New annual accounts for financial year 2025: profit of € 132,142 (▲ 36% vs 2024). Source: NBB ↗
2025 ExecAdvice became a director. NBB
2025 AQLC Management SRL became a director. NBB
2025 Noélise Consulting SRL became a director. NBB
2023 JEAN CLAUDE BIARD became a director. NBB
Dec 28, 1990 New establishment in Couvin. KBO
Aug 6, 1979 Start of the company according to the CBE. KBO

In short

From € 89,465 profit in 2022 to € 132,142 profit in 2025.

Paid € 136,272 in corporate taxes since 2022.

Best year ever: 2025, with € 132,142 profit.

On average € 136,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

B-CHEMICALS INTERNATIONAL HOLDING 100%

The stake of B-CHEMICALS INTERNATIONAL HOLDING comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Phase 3

Behind Phase 3 are ExecAdvice, JEAN CLAUDE BIARD, AQLC Management SRL and Noélise Consulting SRL. The shares are held by B-CHEMICALS INTERNATIONAL HOLDING (100%).

Directors

According to the 2025 annual accounts

ExecAdvice

Director · represented by Gilles Klass

Also active at: CONVERGENT GROUP, B-CHEMICALS INTERNATIONAL HOLDING, LISOCHEM, BAO DEVELOPPEMENT, EXQUANDO

since 2025

JEAN CLAUDE BIARD

Director

Also active at: CONVERGENT GROUP, B-CHEMICALS INTERNATIONAL HOLDING, LISOCHEM

since 2023

AQLC Management SRL

Director · represented by Quentin Maguin

Also active at: CONVERGENT GROUP, B-CHEMICALS INTERNATIONAL HOLDING, LISOCHEM

since 2025

Noélise Consulting SRL

Director · represented by Emilie Van Hamme

Also active at: CONVERGENT GROUP, B-CHEMICALS INTERNATIONAL HOLDING, LISOCHEM

since 2025

Shareholders

B-CHEMICALS INTERNATIONAL HOLDING

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Mousquetaires Gris 35

5660 Couvin

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

CONVERGENT GROUP same network

€ 521,448 gross margin · 2025

B-CHEMICALS INTERNATIONAL HOLDING same network

€ 44,956 gross margin · 2025

LISOCHEM same network

€ 78,729 gross margin · 2025

JEYQ

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0419.617.446

VAT number

BE 0419.617.446

Registered office

Rue des Mousquetaires Gris 35, 5660 Couvin

Names & denominations

Phase 3

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

6 August 1979

Peppol

Active · Active since 27 Oct 2025

Activities · NACE

Vervaardiging van andere anorganische chemische basisproducten

Vervaardiging van andere chemische producten, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Phase 3

Financials

What happened to Phase 3?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions